SELLAS Life Sciences (SLS) Return on Capital Employed Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4,853.00 |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | 34,863.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,863.00 |
| Dec 31, 2025 | 47,840.00 |
| Sep 30, 2025 | 19,175.00 |
| Jun 30, 2025 | 20,194.00 |
| Mar 31, 2025 | 16,440.00 |
| Dec 31, 2024 | -14,092.00 |
| Sep 30, 2024 | -27,105.00 |
| Jun 30, 2024 | -40,962.00 |
| Mar 31, 2024 | -403,281.00 |
| Dec 31, 2023 | 66,045.00 |
| Sep 30, 2023 | -228,586.00 |
| Jun 30, 2023 | -16,782.00 |
| Mar 31, 2023 | -21,666.00 |
| Dec 31, 2020 | 5,044.00 |
| Sep 30, 2020 | -15,297.00 |
| Jun 30, 2020 | -16,172.00 |
| Mar 31, 2020 | 40,765.00 |
| Dec 31, 2017 | -4,481.00 |
| Sep 30, 2017 | 7,245.00 |
| Jun 30, 2017 | 5,354.00 |
| Mar 31, 2017 | -52,137.00 |
| Dec 31, 2016 | 5,777.00 |
| Sep 30, 2016 | -3,755.00 |
| Jun 30, 2016 | -7,948.00 |
| Mar 31, 2016 | -5,207.00 |
| Dec 31, 2015 | -1,707.00 |